Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
Merck’s License and Collaboration Agreement with Kelun-Biotech
Oak Hill Bio’s Development of Rare Autoimmune Diseases Pipeline
Morgan Lewis represented Takeda Pharmaceutical Company Limited in its transaction with clinical-stage rare disease therapeutics company Oak Hill Bio. Oak Hill Bio plans to advance a...